Phage Therapy 2024 Program is Released – Key Dates & Abstract Submission

<br />

Posted in Newsletters

Targeting Phage Therapy 2024 Replay
Phage Therapy 2024 Concluding Remarks by Jean-Paul Pirnay: Towards Personalized Phage Therapy
Jean-Paul Pirnay Wins Best Scientific Contribution at Phage Therapy 2024
Engineered M13 Bacteriophage for Cancer Therapy Wins Best Short Oral at Phage Therapy 2024
Immune Response to Nebulized Phage Therapy in Cystic Fibrosis Patients Wins Best Short Oral at Phage Therapy 2024

Personalized Bacteriophage Therapy: Insights from 100 Consecutive Cases
Exploring the Phageome: Differences in Healthy and Atopic Dermatitis Skin
Untapped Potential: Phage Model Systems as Next-Generation Therapeutic Agents
Armed phages are heading for clinical trials
Vibrio cholerae CBASS System Revolutionizes Antibiotic Sensitivity
Nearly complete structure of bacteriophage DT57C has been revealed
Enhancing Precision in Phage Therapy: Insights from Phage Annotation and Nomenclature
Exploring Phage Therapy: From Biological Mechanisms to Future Directions
Phage Therapy Targets Gut Microbiota for Liver Disease Treatment
Virus Attacks Dormant Bacteria, Offering New Hope in Antibiotic Resistance Fight

Theme: Vogue by Kaira

News & Media